BEVACIZUMAB-BVZR

705 reported adverse events

Drug classes: Vascular Endothelial Growth Factor Inhibitor [EPC]

These side effects are most commonly reported by patients taking BEVACIZUMAB-BVZR:

# Side effect Count
0 OFF LABEL USE 171
1 DEATH 162
2 NEOPLASM PROGRESSION 82
3 FATIGUE 68
4 WEIGHT DECREASED 47
5 HYPERTENSION 46
6 BLOOD PRESSURE INCREASED 44
7 WEIGHT INCREASED 37
8 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32
9 MALAISE 32
See all common reactions for BEVACIZUMAB-BVZR

BEVACIZUMAB-BVZR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BODY SURFACE AREA DECREASED 2 0.0247
1 IMMATURE GRANULOCYTE COUNT INCREASED 5 0.0177
2 ADNEXA UTERI MASS 3 0.0104
3 WHITE COAT HYPERTENSION 3 0.0055
4 GRANULOCYTE COUNT INCREASED 2 0.0049
5 MEAN CELL HAEMOGLOBIN INCREASED 7 0.0042
6 MONOCYTE COUNT DECREASED 5 0.0041
7 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 2 0.0038
8 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 2 0.0036
9 BLOOD PRESSURE DIASTOLIC INCREASED 16 0.0035
See all enriched reactions for BEVACIZUMAB-BVZR